Aligos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ALGS)

Historical Holders from Q3 2024 to Q1 2025

Symbol
ALGS on Nasdaq
CUSIP
01626L204
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
5.48M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.62M
Holdings value
$64.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
32
Number of buys
19
Number of sells
-9
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aligos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ALGS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Adage Capital Management, L.P. 9.38% $3.51M 325K Adage Capital Management, L.P. Dec 31, 2024
ARMISTICE CAPITAL, LLC 4.99% $2.04M 188K Armistice Capital, LLC Dec 31, 2024
BLATT LAWRENCE 3.2% $1.9M 176K Lawrence M. Blatt, Ph.D. Mar 10, 2025

Institutional Holders of Aligos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ALGS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 4 $33.00 $8.25 1
2024 Q4 1.62M $64.5M +$11.8M $39.84 32
2024 Q3 1.69M $14.7M +$14.6M $8.66 27